about
Safety of topical corticosteroids in pregnancyTopical treatments for chronic plaque psoriasisSafety of topical corticosteroids in pregnancyTopical treatments for chronic plaque psoriasisPerinatal safety of topical corticosteroids for pregnant womenKrüppel-like factor 9 is a circadian transcription factor in human epidermis that controls proliferation of keratinocytesTopical calcineurin inhibitors for atopic dermatitis: review and treatment recommendationsConsensus Conference on Clinical Management of pediatric Atopic DermatitisSafety of Topical Medications for Scabies and Lice in PregnancyPimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infantsPerioral dermatitis: a review of the condition with special attention to treatment optionsImprovement of skin condition in striae distensae: development, characterization and clinical efficacy of a cosmetic product containing Punica granatum seed oil and Croton lechleri resin extractPsychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice.Local blockade of glucocorticoid activation reverses stress- and glucocorticoid-induced delays in cutaneous wound healing.Paeonol suppresses solar ultraviolet-induced skin inflammation by targeting T-LAK cell-originated protein kinase.IκB kinase β regulates epithelium migration during corneal wound healingEfficacy and Safety Results of a Drug-Free Cosmetic Fluid for Perioral Dermatitis: The Toleriane Fluide Efficacy in Perioral Dermatitis (TOLPOD) Study.7,8,4'-Trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice.Fluorescence spectroscopy as a tool to detect and evaluate glucocorticoid-induced skin atrophy.Keratinocytes synthesize and activate cortisol.First-trimester nonsystemic corticosteroid use and the risk of oral clefts in Norway.Topical corticosteroid misuse: the Indian scenario.Topical steroid-damaged skinA practical guide to the monitoring and management of the complications of systemic corticosteroid therapyTopical steroid addiction in atopic dermatitis.Side-effects of topical steroids: A long overdue revisit.Pseudoceramide-containing physiological lipid mixture reduces adverse effects of topical steroidsPsoriasis and its managementIdentifying chinese herbal medicine network for eczema: implications from a nationwide prescription database.Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.Determination of Matrine in Rat Plasma after Oral Administration of Novel Korean Herbal Medicine KIOM-MA128 and Application of PK.Striae after topical corticosteroid: Treatment with nonablative fractional laser 1540nm.TriCalm(®) hydrogel is significantly superior to 2% diphenhydramine and 1% hydrocortisone in reducing the peak intensity, duration, and overall magnitude of cowhage-induced itch.Ocular side-effects of topical corticosteroids: what a dermatologist needs to know.Pulsed dye laser in treatment of steroid-induced atrophy.Topical steroid therapy in atopic dermatitis in theory and practiceEstablished corticosteroid creams should be applied only once daily in patients with atopic eczema.Do topical ophthalmic corticosteroids suppress the hypothalmic-pituitary-adrenal axis in post-penetrating keratoplasty patients?Postoperative glucocorticoid enhances recovery after endovascular aortic repair for chronic type B aortic dissection: a single-center experience.Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.
P2860
Q24186366-2D278278-E442-45C7-966D-F9284EC39EA0Q24198258-F653CB71-26F5-4088-807C-C2EA7194D7C1Q24240069-90B25659-132D-4D15-9B27-4775ECCC8665Q24241239-836D2060-0EAF-4692-BADB-97C5B7DD912DQ24242500-FA157B6E-E86F-4520-8B99-AE6E8D0FB4EBQ24338596-05479B2F-5FEE-4A8B-8F2C-BC8337BE5E73Q24597375-65DA5522-EDC6-4C8C-924A-F6CF10DA3AA1Q28071974-A1D6DE17-BAA1-4F5E-A508-647AA3769C2DQ28076817-A176B9AB-78FE-4BF2-8C85-48BDD9E6CFCEQ28086973-5D9DAD95-4E5D-4D01-89C9-1E26FBF4979CQ28235831-AC6B18C9-8EC4-4104-BA59-33AB2E5D60EEQ30361408-252DD53C-B6D6-4531-B2EE-7BE75D15987EQ30480323-84F24DCB-327C-422C-82EB-123796DB2FFCQ30658259-9BEF2B04-11DE-4B5B-A679-7FF49DDA83B7Q33688943-BF74BC52-E3B4-4DD6-A46C-2695FE75A17AQ33802598-20D7F328-CAEC-4D02-AB6A-5F39F1A88832Q34054364-A5DE6A4E-D29C-4B3C-AD93-72A47722AF4DQ34109984-60C44116-7E04-4B42-AE00-93412E956DACQ34128917-FCF22206-BEDA-40CC-818E-D11A93B5E78BQ34166345-09E3BCD3-5369-41E8-844D-36A85649CBFEQ34169484-2967D4E4-45E2-4294-A667-6C82D55FAF09Q34229138-E704EF56-474A-4D36-8D53-4145DBE5F851Q34229144-BFD72264-784D-49DB-A7DB-C6644E3A6D6BQ34364143-8E9B0767-0708-4523-A29A-0F9D177456A6Q34394204-7FB835EC-F7CD-477B-8622-320966C2FFD3Q34447891-97A788C8-42F2-4D3D-8D32-57FA766B36B4Q34709971-67848E86-C18A-4437-9772-DAA42D91CC45Q34997840-0B28D03F-68A9-4DE2-849F-4374BA028B99Q35061535-DC369E99-6E5E-47E9-9842-876424FE165FQ35077866-4FEDB393-5213-49B8-A764-F9CA337EB7D0Q35133799-5CB73E2E-D89A-4339-A437-E980241E1AABQ35535910-640587E3-C96A-422A-AAB9-B3D79BD00C9EQ35560404-AE4237AB-CDAB-4945-9B45-37E334845F38Q35574205-9B8780E6-9662-41EF-BCF6-3BC3A35562C1Q35748051-09F36934-0B71-496B-ABAC-31BFD3503917Q35829085-C565A361-7172-4CC2-8871-1307A0EE265BQ35843612-F6274CB8-8BE0-4B8A-B3D3-65AD40D03AE7Q35955536-D1689651-C278-49D2-A16E-E20B4847BDF9Q35969813-75171301-9217-4471-B26F-D38B6D6B5B6FQ36042131-27BFBB3E-5798-439B-85E2-79DB9EC44DBD
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Adverse effects of topical glucocorticosteroids.
@ast
Adverse effects of topical glucocorticosteroids.
@en
Adverse effects of topical glucocorticosteroids.
@nl
type
label
Adverse effects of topical glucocorticosteroids.
@ast
Adverse effects of topical glucocorticosteroids.
@en
Adverse effects of topical glucocorticosteroids.
@nl
prefLabel
Adverse effects of topical glucocorticosteroids.
@ast
Adverse effects of topical glucocorticosteroids.
@en
Adverse effects of topical glucocorticosteroids.
@nl
P2093
P1476
Adverse effects of topical glucocorticosteroids.
@en
P2093
Robert A Schwartz
Thomas Ruzicka
Ulrich R Hengge
P304
1-15; quiz 16-8
P356
10.1016/J.JAAD.2005.01.010
P407
P577
2006-01-01T00:00:00Z